552c7ae14ClaimMachine-learning antibody profiles differentiated individuals who later developed complicated Crohn's disease from non-complicated Crohn's disease up to approximately 10 years before diagnosis with an AUC value of 0.85.AgreeDisagree
552c7ae14ClaimMachine-learning models integrating early antibody signatures discriminated individuals who would later develop Crohn's disease or ulcerative colitis from healthy controls up to 10 years before diagnosis, with AUC values of 0.90 and 0.84, respectively.AgreeDisagree
552c7ae14ClaimThe Percival artificial intelligence model operates in the background to identify health patterns, clinical outcomes, and connections between CT scans, lab values, and physiology without requiring specific direction to search for particular outcomes.AgreeDisagree
552c7ae14ClaimAstraZeneca and Oracle plan to combine drug development expertise with artificial intelligence and healthcare data to identify eligible patients for clinical trials and monitor safety signalsAgreeDisagree
552c7ae14ClaimPrevious animal model studies showed that the liver is among the organs most susceptible to misalignment between eating and sleep timing.AgreeDisagree
552c7ae14ClaimNight shift workers whose work schedules conflict with natural day-night biological cycles experience elevated rates of obesity and heart disease.AgreeDisagree
552c7ae14ClaimThe World Health Organization Regional Office for Africa used artificial intelligence analysis in the Democratic Republic of Congo to reduce situation report generation time from a full working day to one hour.AgreeDisagree
552c7ae14ClaimResponse teams in the Democratic Republic of Congo fighting the Bundibugyo strain of Ebola virus used Anthropic's Claude model to evaluate digitized health worker field reports.AgreeDisagree
552c7ae14ClaimThe European Academies Science Advisory Council report warned that routine automation by artificial intelligence risks professional deskilling among medical staff during system outages.AgreeDisagree
552c7ae14ClaimVir Biotechnology utilizes its PRO-XTEN masking technology and proprietary dAIsY AI platform to design dual-masked T-cell engager candidates against solid tumorsAgreeDisagree
552c7ae14ClaimProfessor Thomas Thesen of Dartmouth University stated that artificial intelligence chatbots create an explainability black-box problem by failing to explain pattern recognition in human-understandable language.AgreeDisagree
552c7ae14ClaimMerck officially opened Advance, a 120,000-square-foot research facility featuring automated robotics and AI, at its West Point, Pennsylvania campus on October 14, 2026.AgreeDisagree
552c7ae14ClaimIsomorphic Labs established partnerships with major pharmaceutical companies while planning to design internal therapeutic drugs using artificial intelligence.AgreeDisagree
552c7ae14ClaimMoody's warned in August 2026 that banks deploying AI risk systemic dependency on concentrated technology providers, specifically naming OpenAI and Anthropic.AgreeDisagree
552c7ae14ClaimBank of England Governor Andrew Bailey described frontier AI threat capabilities as the most immediate cyber risk facing global financial systems in an August 31, 2026 letter.AgreeDisagree
552c7ae14ClaimOn October 15, 2026, U.K. drugmaker AstraZeneca announced a partnership with artificial intelligence startup Insitro to discover new treatments for cardiometabolic diseasesAgreeDisagree
552c7ae14ClaimAstraZeneca agreed to make an upfront payment of $40 million to Insitro for the artificial intelligence drug discovery collaboration announced on October 15, 2026AgreeDisagree
552c7ae14ClaimThe research collaboration between AstraZeneca and Insitro, announced on October 15, 2026, targets metabolic dysfunction-associated steatohepatitis, a fatty liver condition, and cardiomyopathies, which are diseases affecting the heart muscleAgreeDisagree
552c7ae14ClaimSwiss pharmaceutical maker Roche agreed earlier in 2026 to build a supercomputer in partnership with technology company Nvidia for artificial intelligence drug discoveryAgreeDisagree
552c7ae14ClaimLast month, pharmaceutical company Novo Nordisk partnered with artificial intelligence laboratory Anthropic to utilize the Claude Science platform for drug researchAgreeDisagree